Hans van Houte - May 31, 2022 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Chief Financial Officer
Signature
/s/ Christine Ring, as Attorney-in-Fact for Hans van Houte
Stock symbol
NRIX
Transactions as of
May 31, 2022
Transactions value $
$57,400
Form type
4
Date filed
6/1/2022, 04:57 PM
Previous filing
May 3, 2022
Next filing
Aug 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRIX Common Stock Options Exercise $57.4K +68.3K +3121.65% $0.84* 70.5K May 31, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRIX Employee Stock Option (right to buy) Options Exercise $0 -68.3K -100% $0.00* 0 May 31, 2022 Common Stock 68.3K $0.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested.